Skip to main content
Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
0.880
+0.001 (0.11%)
At close: Feb 21, 2025, 4:00 PM
0.861
-0.019 (-2.16%)
After-hours: Feb 21, 2025, 7:54 PM EST

Kazia Therapeutics Revenue

In the fiscal year ending June 30, 2024, Kazia Therapeutics had annual revenue of 2.48M AUD with 248,000.00% growth. Kazia Therapeutics had revenue of 2.48M in the half year ending June 30, 2024.

Revenue (ttm)
2.48M AUD
Revenue Growth
+248,000.00%
P/S Ratio
1.40
Revenue / Employee
275,667 AUD
Employees
9
Market Cap
4.92M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20242.48M2.48M248,000.00%
Jun 30, 20231,000.00-9.00K-90.00%
Jun 30, 202210.00K-15.17M-99.93%
Jun 30, 202115.18M14.19M1,436.54%
Jun 30, 2020988.11K-451.89K-31.38%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

KZIA News

More News